Vir Biotechnology Inc VIR
News
Vir Biotechnology to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2026 Financial Results
Vir Biotechnology Announces Chief Financial Officer Transition
Vir Biotechnology to Host Conference Call for Second Quarter 2026 Financial Results
Vir Biotechnology, Astellas in $335 Million Licensing Deal for Prostate Cancer Treatment
